Innovative MedTech Past Earnings Performance
Past criteria checks 0/6
Innovative MedTech's earnings have been declining at an average annual rate of -11.6%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 23.5% per year.
Key information
-11.6%
Earnings growth rate
47.4%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 23.5% |
| Return on equity | n/a |
| Net Margin | -488.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Innovative MedTech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2 | -9 | 6 | 0 |
| 30 Jun 24 | 2 | -8 | 5 | 0 |
| 31 Mar 24 | 2 | -2 | 2 | 0 |
| 31 Dec 23 | 2 | -2 | 1 | 0 |
| 30 Sep 23 | 2 | -3 | 1 | 0 |
| 30 Jun 23 | 2 | -4 | 1 | 0 |
| 31 Mar 23 | 2 | -20 | 18 | 0 |
| 31 Dec 22 | 1 | -20 | 18 | 0 |
| 30 Sep 22 | 1 | -19 | 18 | 0 |
| 30 Jun 22 | 1 | -18 | 18 | 0 |
| 31 Mar 22 | 1 | -1 | 1 | 0 |
| 31 Dec 21 | 1 | -3 | 1 | 0 |
| 30 Sep 21 | 1 | -3 | 1 | 0 |
| 30 Jun 21 | 0 | -3 | 1 | 0 |
| 30 Jun 20 | 0 | 0 | 0 | 0 |
| 30 Jun 19 | 0 | 0 | 0 | 0 |
| 31 Oct 14 | 0 | 0 | 0 | 0 |
| 31 Jul 14 | 0 | 0 | 0 | 0 |
| 30 Apr 14 | 0 | 0 | 0 | 0 |
Quality Earnings: IMTH is currently unprofitable.
Growing Profit Margin: IMTH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IMTH is unprofitable, and losses have increased over the past 5 years at a rate of 11.6% per year.
Accelerating Growth: Unable to compare IMTH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IMTH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: IMTH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.